Finance

Lists
KROS:NASDAQ
Keros Therapeutics Inc
$9.47
+0.21%
(+0.020) 1D
Nov 6, 3:41:42 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
$9.74
High
$9.98
Low
$9.46
Mkt. cap
187.76M
Avg. vol.
165.10K
Volume
109.47K
52-wk high
$22.55
52-wk low
$9.37
EPS
-$3.70
Beta
1.13
Shares outstanding
19.83M
No. of employees
92
Open
$9.74
High
$9.98
Low
$9.46
Mkt. cap
187.76M
Avg. vol.
165.10K
Volume
109.47K
52-wk high
$22.55
52-wk low
$9.37
EPS
-$3.70
Beta
1.13
Shares outstanding
19.83M
No. of employees
92
News stories
From web sources and news partners
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current $9.47
$20.00 (+111.19%)
Average
$18.33 (+93.56%)
Lowest
$17.00 (+79.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$20.00
+111.2%
11/06/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
$18.00
+90.1%
09/02/2026
Jason Zemansky
Bank of America Securities
Hold
Reiterated
$17.00
+79.5%
08/11/2026
Yun Zhong
Wedbush
Hold
Maintained
$16.00
+69%
08/04/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
$23.00
+142.9%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
$27.00
+185.1%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$30.00
+216.8%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
$20.00
+111.2%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps